LDB1 Antibody (monoclonal) (M02)
Mouse monoclonal antibody raised against a partial recombinant LDB1.
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND

Application
| WB, E |
|---|---|
| Primary Accession | Q86U70 |
| Other Accession | NM_003893 |
| Reactivity | Human |
| Host | mouse |
| Clonality | Monoclonal |
| Isotype | IgG2b Kappa |
| Clone Names | 2G9 |
| Calculated MW | 46533 Da |
| Gene ID | 8861 |
|---|---|
| Other Names | LIM domain-binding protein 1, LDB-1, Carboxyl-terminal LIM domain-binding protein 2, CLIM-2, LIM domain-binding factor CLIM2, hLdb1, Nuclear LIM interactor, LDB1, CLIM2 |
| Target/Specificity | LDB1 (NP_003884, 1 a.a. ~ 110 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa. |
| Dilution | WB~~1:500~1000 E~~N/A |
| Format | Clear, colorless solution in phosphate buffered saline, pH 7.2 . |
| Storage | Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing. |
| Precautions | LDB1 Antibody (monoclonal) (M02) is for research use only and not for use in diagnostic or therapeutic procedures. |

Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
References
Transcription intermediary factor 1gamma decreases protein expression of the transcriptional cofactor, LIM-domain-binding 1. Howard PW, et al. Biochem Biophys Res Commun, 2010 Jun 4. PMID 20447379.Regulation of LIM-domain-binding 1 protein expression by ubiquitination of Lys134. Howard PW, et al. Biochem J, 2010 Jul 1. PMID 20423330.Regulation of estrogen-dependent transcription by the LIM cofactors CLIM and RLIM in breast cancer. Johnsen SA, et al. Cancer Res, 2009 Jan 1. PMID 19117995.Implementing the LIM code: the structural basis for cell type-specific assembly of LIM-homeodomain complexes. Bhati M, et al. EMBO J, 2008 Jul 23. PMID 18583962.Assembly of the oncogenic DNA-binding complex LMO2-Ldb1-TAL1-E12. Ryan DP, et al. Proteins, 2008 Mar. PMID 17910069.
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.





Foundational characteristics of cancer include proliferation, angiogenesis, migration, evasion of apoptosis, and cellular immortality. Find key markers for these cellular processes and antibodies to detect them.
The SUMOplot™ Analysis Program predicts and scores sumoylation sites in your protein. SUMOylation is a post-translational modification involved in various cellular processes, such as nuclear-cytosolic transport, transcriptional regulation, apoptosis, protein stability, response to stress, and progression through the cell cycle.
The Autophagy Receptor Motif Plotter predicts and scores autophagy receptor binding sites in your protein. Identifying proteins connected to this pathway is critical to understanding the role of autophagy in physiological as well as pathological processes such as development, differentiation, neurodegenerative diseases, stress, infection, and cancer.




